RFK Jr. singled out one study to cut funds for global vaccines. Is that study valid?
Summary
U.S. Health Secretary Robert F. Kennedy Jr. announced that the United States will stop funding Gavi, a global vaccine organization, citing concerns about vaccine safety. He based this decision on a 2017 study claiming children who received the DTP vaccine in the early 1980s had higher mortality rates. Vaccine experts question the study's validity, pointing out the data is very old and other potential flaws.Key Facts
- RFK Jr. announced the U.S. will stop funding Gavi due to vaccine safety worries.
- The decision was based on a 2017 study about the DTP vaccine.
- The DTP vaccine protects against diphtheria, tetanus, and pertussis.
- The study suggested higher death rates in children who got the DTP vaccine in the 1980s.
- Experts interviewed by NPR have raised doubts about the study's validity.
- Concerns highlight the study's data being from the early 1980s.
- Gavi has helped vaccinate over half the world's children in low-income countries.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
